Bank Of America Corp Forma Therapeutics Holdings, Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$7.12 - $20.24 $1.28 Million - $3.63 Million	179,506 Added 161.56%	290,617 $5.8 Million
Q2 2022 Aug 12, 2022	SELL	$5.1 - $10.0 $98,470 - $193,080	-19,308 Reduced 14.8%	111,111 $765,000
Q1 2022 May 16, 2022	SELL	$8.34 - $14.69 $22,784 - $40,133	-2,732 Reduced 2.05%	130,419 $1.21 Million
Q4 2021 Feb 08, 2022	BUY	$13.6 - $24.89 $1.7 Million - $3.1 Million	124,654 Added 1467.04%	133,151 $1.89 Million
Q3 2021 Nov 15, 2021	BUY	$21.22 - $25.7 $1,251 - $1,516	59 Added 0.7%	8,497 $197,000
Q2 2021 Sep 13, 2021	BUY	$22.86 - $30.95 $192,892 - $261,156	8,438 New	8,438 $210,000

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.